Jaguar Gene Therapy Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Jaguar Gene Therapy's estimated annual revenue is currently $12.7M per year.(i)
  • Jaguar Gene Therapy's estimated revenue per employee is $155,000

Employee Data

  • Jaguar Gene Therapy has 82 Employees.(i)
  • Jaguar Gene Therapy grew their employee count by -18% last year.

Jaguar Gene Therapy's People

NameTitleEmail/Phone
1
VP Manufacturing & Supply ChainReveal Email/Phone
2
VP - Corporate Strategy and Program ManagementReveal Email/Phone
3
VP EngineeringReveal Email/Phone
4
SVP, Quality AssuranceReveal Email/Phone
5
VP - Preclinical ProgramsReveal Email/Phone
6
VP, Analytical Development and QCReveal Email/Phone
7
SVP, Corporate Program Strategy and DevelopmentReveal Email/Phone
8
VP, ManufacturingReveal Email/Phone
9
VP, Corporate Communications & Patient AdvocacyReveal Email/Phone
10
Director, Quality AssuranceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Jaguar Gene Therapy?

keywords:N/A

N/A

Total Funding

82

Number of Employees

$12.7M

Revenue (est)

-18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Jaguar Gene Therapy News

2022-03-30 - Samsung to Invest in a U.S. Gene Therapy Development ...

Samsung Group has invested in Jaguar Gene Therapy of the United States to discover innovative technologies and secure competitiveness in the...

2022-03-30 - Jaguar Gene Therapy Announces Samsung and JDRF T1D ...

Jaguar Gene Therapy, LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.5M8222%N/A
#2
$14.8M820%N/A
#3
$20.8M820%N/A
#4
$20.6M82-23%$224.8M
#5
$26.9M8228%N/A